A randomized clinical trial with two doses of an enteral diabetes-specific suplements in elderly patients with diabetes mellitus type 2

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 12, 2013, Pages 1626-1630

  De Luis, Daniel A ^a   Izaola, O ^a   De La Fuente, B ^a   Terroba, M C ^a   Cuellar, L ^a   Cabezas, G ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Diabetes mellitus; Enteral nutrition; Specific formulas

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; MONOUNSATURATED FATTY ACID; PREALBUMIN;

AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG MECHANISM; FAT MASS; FEMALE; HUMAN; MALE; MASS; METABOLIC PARAMETERS; METABOLIC REGULATION; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL PARAMETERS; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; FATTY ACIDS, MONOUNSATURATED; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; NUTRITIONAL STATUS;

EID: 84884318880     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998: 352: 837-853.
2. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
3. JONES BM, STRATTON RJ, HOLDEN C, RUSSELL C, GLENCORSE G, MICKLEWRIGHT A. Trends in Artificial Nutritional support in the UK 2000-2003: Annual report of the British Artificial Nutrition Survey (BANS). Redditch, UK, BAPEN, 2005.
4. DE LUIS DA, ALLER R, IZAOLA O, TERROBA MC, CABEZAS G, CUELLAR LA. Experience of 6 years with HEN in an area of Spain. Eur J CLin Nutr 2006; 60: 553-557.
5. CASHMERE KA, COSTIL DL, CATALAND S, HECKER AL. Serum endocrine and glucose response elicited from ingestion of enteral feedings. Fed Proc 1981; 40: 440A.
6. COULSTON AM. Clinical experience with modified enteral formulas for patients with diabetes. Clin Nutr 1998; 17(Suppl. 2): 46-56.
7. GARG A. High-monounsaturated-fat diets for patients with diabetes mellitus : a meta-analysis. Am J Clin Nutr 1998; 67(Suppl. 3): 577S-582S.
8. DRUETZLER A, BOWEN P, CASHMERE K, HORWITZ A. Acute and chronic response of glucose tolerance to a soy polysaccharide enriched liquid formula diet. Fed Proc 1985; 44: 1499.
9. KOIVISTO VA, YKI-JARVINEN H. Fructose and insulin sensitivity in patients with type 2 diabetes. J Intern Med 1993: 223: 145-153.
10. ELIA M, CERIELL A, LAUBE H, SINCLAIR AJ, ENGFER M, STRATTON RJ. Enteral nutritional support and use of diabetes.secific formulas for patients with diabetes. A Systematic review and meta-analysis. Diabetes Care 2005; 28: 2267-2279.
11. AMERICAN DIABETES ASSOCIATION. Nutrition recommendations and interventions for diabetes. Diabetes Care 2010; 30: s48-s65.
12. DE LUIS DA, IZAOLA O, ALLER R, CUELLR L, TERROBA MC, MARTIN T, CANBEZAS G, ROJO S, DOMINGO M. A randomized clinical trial with two enteral diabetes specific supplements in patients with diabetes mellitus type 2: metabolic effects. Eur Rev Med Pharmacol Sci 2008; 12: 261-266.
13. SINCALIR AJ GADSBY R, PENFOLD S, CROXSON SC, BAYER AJ. Prevalence of diabetes in care home residents. Diabetes Care 2001; 24: 1066-1068.
14. LUKASKI H, JOHSON PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810-817.
15. MAYR P, MERTLE-ROETZER M, LAUSTER F, POHL M, HASLBECK M, ERIKSEN J, et al. Metabolic control in type 2 diabetes tube fed patients after brain damage during long-term treatment with a new low carbohydrate, high monounsaturated fatty acid containing enteral formula versis a standard-like formula: a randomized, prospective controlled, double blind multi centre trial.Clin Nutr 2005; 23: 1497-1498.
16. MCCARGAR LJ, INNIS SM, BOWRON E, LEICHTER J, DAWSON K, TOTH E, WALL K. Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM.Mol Cell Biochem 1998; 188: 81-89.
17. MESEJO A, ACOSTA JA, ORTEGA C, VILA J, FERNANDEZ M, FERRERES J, SANCHIS JC, LOPEZ F. Comparison of a high-protein disease specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nur 2003; 22: 295-305.
18. WANG W, ZHANG YF, ZHOU D, LIU Z, HONG X.Open-label, randomized multiple-center, parallel study comparing glycemic responses and safety profiles of Glucerna versus Fresubin in subjects of type 2 diabetes mellitus. Endocrine 2008; 33: 45-52.
19. POHL M, MAYR P, MERTL-ROETZER M, LAUSTER F, HASLBECK M, Hipper B, Steube D. Glycemic control in patients with type 2 diabetes mellitus with type 2 diabetes mellitus with a specific disease enteral formula: stage II of a randomized, controlled multicenter trial. J Parenter Enteral Nutr 2009; 33: 37-49.
20. PETERS AL, DAVIDSON MB. Effects of various enteral feeding products on postprandial blood glucose response in patients with type 1 diabetes. J Parenter Enteral Nutr 1992; 16: 69-74.
21. FINNEY SJ, ZEKVELD C, ELIA A. Glucose control and mortality in critically ill patients. JAMA 2003; 31: 359-366.
22. GRAHM TW, HARRINGTON TR, ISAAC RM. Low carbohydrate with fiber enteral formula impedes development of hyperglycaemia in patients with acute head injury (abstract). Clin Res 1989; 37: 138A.
23. LEON SANZ M, GARCIA LUNA PP, SANZ PARIS A, GOMEZ CANDELA C, CASIMIRO C, CHAMORRO J, PEREIRA-CUNILL JL, MARTIN-PALMERO A, TRALLERO R, MARTÍNEZ J, ORDÓÑEZ FJ, GARCÍA-PERIS P, CAMARERO E, GÓMEZ- ENTERRÍA P, CABRERIZO L, PEREZ-DE-LA-CRUZ A, SÁNCHEZ C, GARCÍA-DE-LORENZO A, RODRÍGUEZ N, USÁN L; ABBOTT SPAI-97-004 STUDY COOPERATIVE GROUP. Glycemic and lipid control in hospitalized type 2 diabetic patients: evluaation of 2 enteral nutrition formulas. J Parenter Enteral Nutr JPEN 2005; 29: 21-29.
24. CERIELLO A, LANSINK M, ROUWS CH, VAN LAERE KM, FROST GS. Administration of a new diabetes-specific enteral formula resutls in an improved 24 h glucosa profile in type 2 diabetic ptients. Diabetes Res Clin Pract 2009; 84: 259-266.
25. ALISH CJ, GARVEY WT, MAKI KC, SACKS GS, HUSTEAD DS, HEGAZI RA, MUSTAD VA. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther 2010; 12: 419-425.